drugset / Trial / NCT02209779
Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective was to determine the effects of BIRB 796 BS on CRP and clinical parameters in Rheumatoid Arthritis as measures of efficacy, and on population pharmacokinetics and safety parameters
Timeline
- Start
- 2001-05
- Primary completion
- 2002-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIBR 796 BS | Unknown | 5 mg | Oral |
| Subject | BIBR 796 BS | Unknown | 10 mg | Oral |
| Subject | BIBR 796 BS | Unknown | 20 mg | Oral |
| Subject | BIBR 796 BS | Unknown | 30 mg | Oral |